CIK 0001896212
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
CDT Equity Inc.
Sign in to watch- Ticker
- CDT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 873272543
- Phone
- +1 646-491-9132
- Business address
- 4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES, FL, 34103
- Former names
- CONDUIT PHARMACEUTICALS INC., Murphy Canyon Acquisition Corp.
Securities
- CDT Common Stock Nasdaq
- CDTTW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 2 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-19 | Bligh James CFO | Grant or award | +480,000 | 480,024 | ||
| 2024-11-18 | Bligh James Interim CFO | Grant or award · Stock Option (Right to Buy) | +1,890,000 | $0.09 | $174K | 1,890,000 |
| 2024-06-11 | Bligh James Interim CFO | Grant or award | +37,272 | 37,272 | ||
| 2023-12-01 | Bligh James Director | Grant or award · Stock Option (Right to Buy) | +223,634 | $5.51 | $1.2M | 223,634 |
Page 1 of 1 · 4 trades